LabGenomics Co., Ltd. (KOSDAQ:084650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,759.00
-57.00 (-3.14%)
Jan 30, 2026, 3:30 PM KST

LabGenomics Revenue

LabGenomics had revenue of 23.04B KRW in the quarter ending September 30, 2025, with 6.43% growth. This brings the company's revenue in the last twelve months to 89.36B, up 6.71% year-over-year. In the year 2024, LabGenomics had annual revenue of 85.90B with 20.85% growth.

Revenue (ttm)
89.36B
Revenue Growth
+6.71%
P/S Ratio
1.51
Revenue / Employee
629.32M
Employees
142
Market Cap
134.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202485.90B14.82B20.85%
Dec 31, 202371.08B-73.70B-50.90%
Dec 31, 2022144.77B-57.63B-28.47%
Dec 31, 2021202.41B82.93B69.41%
Dec 31, 2020119.48B86.30B260.14%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
HLB bioStep71.47B
C&R Research63.97B
DreamCIS62.06B
DT&CRO CO.44.36B
WOOJUNG BIO37.12B
P&K Skin Research Center22.13B
BioInfra21.92B
Hyundai ADM Bio9.74B
Revenue Rankings